DanielDLanglebenMD

Psychiatry • Philadelphia, PA

Addiction

Associate Professor, Psychiatry, Perelman School of Medicine

Join to view full profile

Are you Dr. Langleben?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 24 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
3535 Market St
Philadelphia, PA 19104
Phone+1 215-746-6700

Summary

Dr. Daniel Langleben, MD is a board certified psychiatrist in Philadelphia, Pennsylvania. He is currently licensed to practice medicine in Pennsylvania, New Jersey, and West Virginia. He is affiliated with Hospital of the University of Pennsylvania and Philadelphia Veterans Affairs Medical Center.

Education & Training

Stanford Health Care-Sponsored Stanford UniversityResidency, Nuclear Medicine, 1997 - 1999
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Radiology-Diagnostic, 1993 - 1995
Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Psychiatry, 1991 - 1993
Drexel University College of Medicine/Hahnemann UniversityInternship, Transitional Year, 1990 - 1991
The Hebrew University of Jerusalem Hadassah Medical SchoolClass of 1988

Certifications & Licensure

CA State Medical License 1996 - 2026
WV State Medical License 2019 - 2026
PA State Medical License 1990 - 2024
NJ State Medical License 2020 - 2021
NY State Medical License 1993 - 1997
American Board of Psychiatry and Neurology Psychiatry
American Board of Psychiatry and Neurology Addiction Psychiatry

Clinical Trials

CURE Addiction Center of Excellence: Brain Mechanisms of Relapse and Recovery Start of enrollment: 2012 Jan 01
Completed
Phase 2
Brain Mechanisms of Pharmacotherapy in Opioid Use Disorder Start of enrollment: 2025 Feb 01
Not yet recruiting
Phase 2

Publications & Presentations

PubMed

Medial prefrontal neuroplasticity during extended-release naltrexone treatment of opioid use disorder - a longitudinal structural magnetic resonance imaging study.
Zhenhao Shi, Xinyi Li, Dustin R Todaro, Wen Cao, Kevin G Lynch
Translational Psychiatry. 2024-09-05
Blood pressure response to extended-release naltrexone in heroin and prescription opioid users and its implications for cardiovascular morbidity.
Zhenhao Shi, Daniel D Langleben, David Rott, Mark Albanese, Igor Elman
Journal of Addictive Diseases. 2024-03-31
Collateral Damage: Neurological Correlates of Non-Fatal Overdose in the Era of Fentanyl-Xylazine.
Dustin R Todaro, Nora D Volkow, Daniel D Langleben, Zhenhao Shi, Corinde E Wiers
Neuroscience Insights. 2024-01-01

Press Mentions

Is This Proof Brain Scans Can Read Our Minds? Special Type of MRI Translated Brainwaves into ImagesAugust 23rd, 2022
Could Brain Scans Determine Guilt or Innocence in Court?November 10th, 2017
The Problem of Lie DetectionNovember 15th, 2016
Join now to see all

Grant Support

Functional MRI Of Anti-Tobacco Public Service AnnouncementsNational Institute On Drug Abuse2007–2010
Functional Neuromaging Of Cue-Induced Heroin CravingNational Institute On Drug Abuse2003–2007